Tsallake zuwa abun ciki
Kayan aikin sarrafa kansu, isarwa a ko’ina cikin duniya
Can Hybrid Control Solve Biomanufacturing's Dual Challenges?

Shin Sarrafa Hadaka na Iya Warware Kalubalen Biyu na Biomanufacturing?

Wannan labarin yana bayyana dalilin da ya sa tsarin haɗaɗɗen gine-ginen PLC/DCS na Emerson yake yin gaba da tsarin sarrafawa na gargajiya da aka raba a samar da rukunin bioreactor. Yana tattauna saurin amsa, daidaiton kowane batch, faɗaɗa iya aiki (scalability), rage kuɗi, bin ka’ida (compliance), da ainihin munanan shari’o’in da aka tabbatar daga Eli Lilly da Sartorius.

Dalilin Da Ya Sa Emerson PLC/DCS Hybrid Control Ke Mamaye Samar da Guguwar Bioreactor na Zamani

1. Matsalar Nake-naken Dual Control a Biomanufacturing

Gungun bioreactor suna buƙatar amsa ta saurin lissafi (logic) da kuma daidaitaccen sarrafa tsari (process control) a lokaci guda. Tsofaffin tsarin sarrafawa ba sa iya ba da duka biyun. Sakamakon haka, kuskuren daidaiton “batch” yana kai 3–8% a manyan tsirran fermentation. Wannan rashin daidaituwa yana haifar da matsalolin aiki da ke ƙara kuɗin samarwa.

2. Dalilin da Ya Sa PLC da DCS Masu Zaman Kansu Ke Gajiyawa

PLC na gargajiya suna yin “scan” a cikin 1–5ms amma ba su da asalin tsarin sarrafa “batch”. DCS na gargajiya yana tabbatar da daidaitaccen daidaita PID, amma yana da jinkirin amsa na 50–100ms. Saboda haka, masana’antar biopharma na fuskantar ƙuntatawa wajen faɗaɗa kayan aiki da kuma matsalar daidaita bayanai. Waɗannan iyakoki kai tsaye suna shafar ingancin samfur.

3. Ƙirƙirar Sabuwar Tsarin Hybrid na Haɗaɗɗen Emerson

Emerson DeltaV PK controller yana karya warewar kayan aiki da software. Yana ci gaba da “I/O scanning” mai saurin 1ms ga na’urorin filin (field actuators). A lokaci guda kuma, yana ɗauke da ci-gaba PID da ƙananan “batch” na GMP. Bugu da ƙari, CHARM electronic marshalling yana rage aikin wayoyi da daidaitawa ƙwarai. Sakamakon haka, dandali guda ɗaya ne ke haɗa discrete logic, sarrafa tsari (process regulation), da jere-jeren “batch sequencing”.

4. Auna Faɗaɗa Ƙarfi da Ajiye Kuɗi

Faɗaɗa ƙarfin aiki na gargajiya na buƙatar sabon controller ɗaya ga kowane bioreactor 2–3. Amma hybrid controller na Emerson na iya tallafawa har zuwa bioreactors 16 a kan controller ɗaya. Wani CDMO na matsakaicin girma ya faɗaɗa daga raka’a 4 zuwa 16 ba tare da ƙara ko guda ɗaya controller ba. Wannan salo ya rage kuɗin kayan aiki da 65% kuma ya rage lokacin commissioning daga makonni 4 zuwa mako 1.

5. Daidaitaccen Sarrafawa da Bayanai na Bin Ka’ida

Nasarar fermentation tana dogara ne kan daidaiton pH da “dissolved oxygen”. Tsarin hybrid na Emerson yana ba da ±0.02 na “units” na pH kuma yana kiyaye dissolved oxygen a cikin ±1.5% na ƙimar da aka saita. Ta amfani da Rosemount 3051S transmitters, kuskuren auna tsari ya faɗi daga 5% zuwa ƙasa da 0.05%. “Audit trail” da aka gina a ciki yana rikodin bayanan kowane “batch” 100% ta atomatik, yana cika cikakken buƙatun FDA da GMP.

6. Fahimtar Masani: Dalilin Da Ya Sa Hybrid Control Ke Yin Nasara

PLC kaɗai yana mai da hankali kan logic amma yana watsar da daidaiton bin ka’ida na tsari. DCS kaɗai yana fifita kwanciyar hankali amma ba zai iya biyan buƙatar saurin motsin actuators ba. A cikin shekaru 15 na aikina a filin injiniyan sarrafawa, na ga cewa tsarin hybrid ya yi daidai da yanayin samar da “batch” mai ɗan lokaci na biopharma. Yana daidaita saurin aiki, daidaitaccen sarrafawa, da bin ka’ida cikin tsari. Bugu da ƙari, tsarin modular ɗinsa yana tallafawa sabunta bioreactor da aka keɓance.

7. Misalan Aikace-aikacen Masana’antu da Aka Tabbatar

Misali 1: Sabunta Layin Fermentation na Eli Lilly
Eli Lilly ta sabunta tsarin da ya kai shekara 15 da Emerson DeltaV hybrid architecture. Sabon tsarin yana tallafawa tarin sigina na dukan tsari har tashoshi 350. Ya rage lokacin shigarwa da tantancewa da 50%. Abu mafi muhimmanci, adadin “batch” ɗin da suka yi nasara ya ƙaru daga 92% zuwa 99.6% bayan sabuntawar.

Misali 2: Aikin Tallafawa Bioreactor na Sartorius
A 2023, Emerson ta yi haɗin gwiwa da Sartorius don haɗa asalin DeltaV da Biostat STR reactors. Standardized library ɗin ya rage lokacin ɗaura kayan aiki da juna da 80%. Ya magance dogon matsalar warewar bayanai tsakanin na’urori daban-daban a layukan bio-production.

Ƙarin Bayanai na Aikin Fage
Wani CDMO na biopharma ya ruwaito cewa ba su ƙara ko ɗaya controller ba lokacin da suka faɗaɗa daga reactors 6 zuwa 18. Tsarin hybrid ya ci gaba da kula da daidaiton sarrafa zafin jiki na ±0.5% a dukkan tukunyar (vessels). Bugu da ƙari, yawan faɗakarwa (alarms) ya faɗi da 70% saboda ingantacciyar daidaita PID da saurin amsa logic.

8. Shawarwari na Aiki ga Injiniyoyi

Lokacin da kuke shirin sabunta guguwar bioreactor, ku fara da tantance saurin “scan” na controller, ikon sarrafa “batch”, da fasalin bin ka’idar FDA. Yi amfani da electronic marshalling don rage kuskuren wayoyi. Koyaushe ku tabbatar da integration libraries tare da manyan masu samar da reactors kamar Sartorius ko Thermo Fisher. Hybrid control ba zaɓi ne kawai ba yanzu; shi ne ma’aunin da ake bi a masana’antun bio na zamani.

An rubuta ta Song Mingyuan, injiniyan “automation” mai ƙwarewa a PLC, DCS da manyan irinansu na sarrafa masana’antu na ƙasashen waje don aikace-aikacen petrochemical.

Komawa zuwa Bulog